KC7F2
KC7F2 is a small molecule inhibitor of the HIF-1 signaling pathway, exhibiting promising anti-tumor properties. It is utilized in cancer research to study hypoxia response mechanisms, demonstrating efficacy in both cellular assays and in vivo tumor models.
Product Specifications
CAS Number
927822-86-4
Product Name Alternative
Inhibit, KC7F2, KC-7F2, Inhibitor, Hypoxia-inducible factors, HIF, HIF Prolyl-Hydroxylase, HIF ProlylHydroxylase, HIF/HIF Prolyl-Hydroxylase, HIF/HIFProlylHydroxylase, HIF/HIF ProlylHydroxylase, HIFs, HIFProlylHydroxylase, HIF-PH, HIF-1α
Field of Research
Cell Biology, Neuroscience
Purity
>98%
Bioactivity
HIF-1a Inhibitor
Form
Powder
Solubility
Soluble in DMSO (up to at least 25 mg/ml)
Smiles
NS (=O) (=O) c1cc (Cl) cc (CCSSCCc2cc (Cl) cc (c2Cl) S (N) (=O) =O) c1Cl
Molecular Formula
C16H16Cl4N2O4S4
Molecular Weight
570.4
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
N, N'- (Dithiodi-2,1-ethanediyl) bis[2,5-dichlorobenzenesulfonamide
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog